Navigation Links
BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease

ase patients, but more importantly, it will produce great savings. Given the growing financial strains on the U.S. healthcare system, our message is being met with great enthusiasm by payers, employers, and other stakeholders," Montano said.

About The Bruckner Group (BGI):

The Bruckner Group provides strategic advice to pharmaceutical and biotechnology executives. BGI is the leading expert in healthcare value strategy, helping pharmaceutical and biotechnology companies enhance and maximize the healthcare value of new therapies in development, prove that value at launch to payers and other stakeholders, and leverage that value post-launch to dominate markets.

Contact

The Bruckner Group
David Balekdjian, 781-245-4454
Partner


'"/>




Page: 1 2

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
3. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
4. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
5. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
6. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
9. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
10. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
11. Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research

Post Your Comments:
(Date:11/6/2009).../ -- NuVasive, Inc. (Nasdaq: NUVA ), a medical de...nimally disruptive surgical treatments for the spi...Lambert as Executive Vice President and Chief Fina...mpany also announced several other Executive Manag...llent complement to the NuVasive family," said Ale...
(Date:11/6/2009).../ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a b... small-molecule therapeutics for the treatment of ...), today reported recent accomplishments and finan... ended September 30, 2009. ,, (Logo: http://...,, "Since our last quarterly update, we have co...
(Date:11/6/2009)...o Inc., in collaboration with scientists at the Ce.... Louis University, and the University of Hong Kon... in the peer-reviewed journal PLoS ONE. These two...174; ) may play a potentially important role for t...nza A(H1N1) and drug-resistant influenza. ,, D...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Impaired kidney function linked to cognitive decline in elderly 58418 1Impaired kidney function linked to cognitive decline in elderly 58418 2Light photosynthesis help bacteria invade fresh produce 10139 1Light photosynthesis help bacteria invade fresh produce 10139 2Director of UT Southwestern center honored with first international neurology medal 58412 1Director of UT Southwestern center honored with first international neurology medal 58412 2
...Mar 20, 2007 - Arrowhead,Research Corporation (NAS...idiary Calando Pharmaceuticals has published,resul...ciences,(PNAS) of the first non-human primate stud...lead siRNA therapeutic candidate., Calando is usin...ic delivery systems and siRNA design to create new...
...)--Mar 20, 2007 - Australian,biotechnology company... results from its Phase IIb trial for apricitabine...anscriptase inhibitor,(NRTI) being developed for t...g-resistant HIV., The Phase IIb trial compared the...f patients with drug-resistant HIV with,the effect...
Other Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Avexa Reports Positive Phase IIb Result 2Avexa Reports Positive Phase IIb Result 3Avexa Reports Positive Phase IIb Result 4
(Date:11/7/2009)...ire-USNewswire/ -- The U.S. bishops November 7 urg... for the Stupak-Ellsworth Amendment to the health ...tur-Dahlkemper-Lipinski-Smith Amendment will keep ...nd conscience protections in the Affordable Health..., The letter was signed by Cardinal Justin Rigali...
(Date:11/7/2009)...youth will rebel, expert says , , SATURDAY... to behave badly if their parents expect them to, ... they are simply being realistic might actually co...uchanan, a psychology professor at Wake Forest Uni...ersity news release. "Negative expectations on the...
(Date:11/7/2009)...lsquo;sweatox’ or ‘Boytox’, the ...nti-ageing jab ‘Breastox’ – or b...e;colletage, can reduce the appearance of wrinkles...easts, leaving smoother, younger-looking skin. , ...- Transform, the UK’s largest group of cosm...
(Date:11/6/2009)...US, Ohio, Nov. 6 Authentidate Holding Corp. (Nasd... Information Exchange and workflow management serv...rybe® Healthcare to be easily integrated with...n systems, Definitive Homecare Solutions, CPR+(TM)...+ Integrated Solutions Provider program, a program...
(Date:11/6/2009)...care Trust of America, Inc. (the "REIT"), a self-m...announced the execution of a Purchase and Sale Agr...ce building located in Englewood, Colorado for app...cal Center is located within the Englewood City Ce...district. Hampden Place is located near the Swedis...
Breaking Medicine News(10 mins):Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 2Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 4Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 3
... Hy Isenbaum served as Chair of the Bioniche Board... -, BELLEVILLE, ON, April 18 /PRNewswire-...), a research-based, technology-driven Canadian,bi...ciences," said Graeme McRae,the Company,s Presiden...
... Berlin, Germany: Acupuncture provides effective ...ated with the anti-oestrogen tamoxifen following s...h presented today (Friday) at the 6th European Bre...told a news briefing that breast cancer patients w...
...EATTLE, April 17 The state,s Life Sciences Discov...ormal phase 1 clinical-trials,program to test new ...er,Research Center. Announced this evening, the gr...rs, in,collaboration with local biotechnology and ...
...ANTA MONICA, Calif., April 17 Consumer,Watchdog t...s to begin,reinstating the insurance coverage of p...reds of thousands of dollars in medical debt when ...complete and retroactive, with no gap in coverage ...
...AGHDAD, Iraq, April 17 The U.S. Agency for,Intern...(MoH) have signed a,Memorandum of Understanding (M...fort to accelerate gains in the health sector,s ab...egic cooperation between the MoH and,USAID,s Tatwe...
...T. LOUIS, Mo., April 17 Young Innovations,Inc. (N...ast its first,quarter earnings results with a live...y, April 24, 2008 at 11:00 a.m. Central Time. A li...lso be available through the Company,s website, h...
Other Medicine News:Health News:Bioniche Reports the Passing of its Board Chair 2Health News:Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen 2Health News:Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program 2Health News:Consumer Watchdog Praises CA HMO Regulator's Promise to Reinstate Health Coverage for Wrongfully Cancelled Patients; Cautions That All Health Costs During Gap Must be Covered 2Health News:Iraq's Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management 2Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: